Principal Healthcare Innovators Index ETF

Добавить в список отслеживания Добавить в список отслеживания
Добавить в портфель Добавить в портфель

Основные параметры

Цена последней сделки 64.46
Код ценной бумаги BTEC
Полное наименование Principal Healthcare Innovators Index ETF
Объем 177920000000
Изм за день, % 0.02
Комиссия 0.42
Дата основания Aug 19. 2016
Ссылка ссылка
Тип актива Equity
Индекс NASDAQ U.S. Health Care Innovators Index
Регион North America
Средний P/E 14.52
Дивиденды 0.33
5 летняя доходность
3 летняя доходность 99.17
Годовая доходность 71.52
Бета 1.26
Валюта usd

Топ эмитентов

Эмитент Доля, %
Moderna 5.2
Zimmer Biomet Holdings 2.72
Teladoc Health, Inc. 2.63
Exact Sciences Corporation 2.58
Horizon Therapeutics Public Limited Company 2.2
Alnylam Pharmaceuticals, Inc. 2.07
Guardant Health, Inc. 1.92
Seagen 1.86
Novavax, Inc. 1.81
BioMarin Pharmaceutical 1.77
10x Genomics, Inc. 1.55
Elanco Animal Health 1.47
Penumbra, Inc. 1.23
CRISPR Therapeutics AG 1.17

Похожие ETF

Описание Principal Healthcare Innovators Index ETF

The Principal Healthcare Innovators Index ETF (BTEC) tracks an index of U.S. health care stocks, avoiding large-cap and less liquid companies. The index aims to score companies based on their investment in researching and developing innovative medicines, therapies, equipment, and facilities. The portfolio includes the highest ranked 150 to 200 companies. Top holdings include Seattle Genetics, Exact Sciences Corp. and Moderna, which became a household name for its vaccine efforts early the 2020 coronavirus pandemic.

BTEC’s management fee is lower than the average for the ETFdb health and biotech equities category, but there a number of less expensive funds in the space. BTEC has been on the market since 2016 but hasn’t gathered the assets of its more seasoned competitors.This may be why BTEC trades at wider spreads than the he Fidelity MSCI Health Care Index ETF (FHLC), the iShares U.S. Health Care ETF (IYH), the Health Care Select Sector SPDR Fund (XLV), and the Vanguard Health Care ETF (VHT), all of which offer more liquidity — in some cases at a fraction of the price. Investors can also take a look at the iShares Nasdaq Biotechnology Fund (IBB) and Goldman Sachs Human Evolution ETF (GDNA). For an actively-managed fund that has shown consistent outperformance, there’s also the ARK Genomic Revolution ETF (ARKG).